| 000 | 01734 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513140537.0 | ||
| 264 | 0 | _c19980506 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0767-3981 | ||
| 024 | 7 |
_a10.1111/j.1472-8206.1998.tb00925.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHong, K W | |
| 245 | 0 | 0 |
_aThe in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _c1998 |
||
| 300 |
_a64-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-Sarcosine-8-Isoleucine Angiotensin II _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta, Thoracic _xmetabolism |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCerebellum _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aIodine Radioisotopes |
| 650 | 0 | 4 |
_aLosartan _xpharmacology |
| 650 | 0 | 4 | _aMembranes |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 1 |
| 650 | 0 | 4 | _aReceptor, Angiotensin, Type 2 |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 700 | 1 | _aKim, C D | |
| 700 | 1 | _aLee, S H | |
| 700 | 1 | _aYoo, S E | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 12 _gno. 1 _gp. 64-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1472-8206.1998.tb00925.x _zAvailable from publisher's website |
| 999 |
_c9490868 _d9490868 |
||